IRF5 and non-Hodgkin lymphoma: NHL and Sjögren’s syndromeBCL2 (NHL) and IRF5 (Sjögren’s Syndrome) a potential cross-pathway interaction is suggested by the connection between BCL2’s role in apoptotic control in NHL and IRF5’s role in the immunological response in Sjögren’s syndrome.